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INTRODUCTION
Aspirin-exacerbated respiratory disease (AERD) presents se-
vere clinical symptoms and is frequently associated with chron-
ic eosinophilic rhinosinusitis and nasal polyposis. Increased 
cysteinyl leukotrienes are potent pro-inflammatory mediators 
and bronchoconstrictors in AERD pathogenesis. Szczeklik
1 has 
hypothesized that AERD develops as the result of chronic viral 
infection. Recently, it has been shown that eosinophils activat-
ed via Toll-like receptor 3 (TLR3) might be more able to recruit 
leukocytes to sites of inflammation, and that eosinophils might 
function as a link between viral infection and exacerbation of 
allergic disease.
2 Viral respiratory infections have been suggest-
ed to contribute to allergic sensitization and development of 
asthma, and in subjects with already established asthma, they 
are known to exacerbate the allergic disease.
3 Aspirin hypersen-
sitivity is diminished in some AERD patients during acyclovir 
treatment of herpes simplex infection.
4 Moreover, elevated lev-
els of IgG4, derived from chronic antigenic stimulation of viral 
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origin, have been noted in AERD patients.
5 In another study, 
exacerbation of AERD with airway infection of respiratory syn-
cytial virus was reported.
6
Although there are a few published studies on the association 
between viral infection and AERD, no clear mechanism(s) be-
hind virus-induced AERD has been described. One possible ex-
planation is direct activation by viral components through the 
TLRs. The TLR family comprises TLR1–TLR10, each of which 
recognizes a conserved microbial structure and then initiates a 
host defense response.
7,8 The virus-recognizing TLRs are TLR3, 
TLR7/8, and TLR9, which respond to viral double-stranded RNA 
(dsRNA), single-stranded RNA, and CpG–DNA, respectively.
8–11 
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Purpose:  Although the mechanism of virus-induced, aspirin-exacerbated respiratory disease (AERD) is not known fully, direct activation of viral 
components through Toll-like receptor 3 (TLR3) has been suggested. TLR3 recognizes double-stranded RNA (dsRNA), and activates nuclear factor-κB 
and increases interferon-γ, which signals other cells to induce airway inflammation in asthma. Considering the association of TLR3 in viral infections 
and AERD, we investigated whether promoter and non-synonymous variants of TLR3 were associated with AERD.  Methods:  The three study groups, 
203 with AERD, 254 with aspirin-tolerant asthma (ATA), and 274 normal healthy controls (NC) were recruited from Ajou University Hospital, Korea. 
Two polymorphisms, -299698G>T and 293391G>A [Leu412Phe], were genotyped using primer extension methods.  Results:  Genetic associations 
were examined between two genetic polymorphisms of TLR3 (-299698G>T and 293391G>A [Leu412Phe]) in the three study groups. AERD patients 
that carried the GG genotype of 293391G>A showed a significantly lower frequency compared with ATA in both co-dominant (P=0.025) and domi-
nant models (P=0.036). Similarly, in the minor allele frequency, the A allele was significantly higher (P=0.023) in AERD compared with ATA for this 
polymorphism. AERD patients who carried HT2 [GA] showed a significantly higher frequency than other haplotypes in co-dominant (P=0.02) and re-
cessive (P=0.026) models.  Conclusions:  Our findings suggest that the -299698G>T and 293391G>A [Leu412Phe] polymorphisms of the TLR3 gene 
are associated with the AERD phenotype.
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TLR3 recognizes dsRNA, activates nuclear factor (NF)-κB, and 
increases interferon (IFN)-γ, which is a signal to other cells and 
increases antiviral defenses. Mutation of the TLR3 gene is re-
sponsible for susceptibility to viral infection and may induce 
asthma.
12 As functional deterioration of TLR3 can predispose 
individuals to increased susceptibility to viral infections, the de-
tection of TLR3 polymorphisms could be informative for risk 
assessment in AERD susceptibility. Moreover, no report is avail-
able on the genetic loci of TLR3 in subjects with AERD; however, 
polymorphisms in the TLR3 gene have been correlated with dis-
ease susceptibility, including to sepsis, immunodeficiency, ath-
erosclerosis, Stevens–Johnson syndrome (SJS), and asthma.
13–15
Genetic variations in the TLR3 non-synonymous variant (Le-
u412Phe) have been correlated with reduced ability to control 
viral infection. The frequency of this coding single nucleotide 
polymorphism (SNP) was higher in asthmatics (41%) compared 
with European Americans (26.97%), Asians (30.1%), and the 
overall population (20%), indicating that the link between this 
SNP and asthma phenotypes is induced by viral infection.
12
Given the association between TLR3 and viral infection, and 
the pathogenic mechanisms for viral-induced exacerbation of 
AERD, we examined the possibility of a genetic predisposition 
to AERD.
MATERIALS AND METHODS
Study subjects and phenotyping
The case–control study was performed in three groups of pa-
tients: 203 with AERD, 254 with aspirin-tolerant asthma (ATA), 
and 274 normal controls (NCs), who were recruited from Ajou 
University Hospital, Suwon, South Korea. The diagnosis of AERD 
was based on a positive response to a lysine-acetyl salicylic acid 
(ASA) bronchoprovocative test, which was performed on all 
study subjects according to a previously described method.
16 
Changes in FEV1 were followed up for 7 hour after the final as-
pirin challenge. The ASA-induced change in FEV1 was calculat-
ed as the percentage of post-challenge FEV1 relative to the pre-
challenge FEV1, and was defined as positive if the FEV1 level 
declined by >20% from baseline.
Methacholine bronchial challenge tests were performed as de-
scribed previously.
17 NCs were chosen from the general popu-
lation using a screening questionnaire, which had to indicate 
no history of respiratory symptoms or aspirin hypersensitivity. 
All NC subjects also exhibited an FEV1 >80% of the predicted 
value, provocation concentration (PC20) of methacholine >25 
mg/mL, and normal findings on simple chest radiograms. Ato-
py was defined as one or more positive reactions on a skin prick 
test using 12 common aeroallergens (Bencard, Brendford, UK), 
with histamine and saline controls. To measure specific IgE, ve-
nous blood was collected from the antecubital vein, allowed to 
clot for 1–3 hour at 4°C, and centrifuged (1,500 g, 10 minutes, 
4°C). The serum was aspirated, separated, and stored in ali-
quots at -20°C until analysis. Serum total IgE was measured us-
ing the UniCAP system (Phadia, Valinge, Sweden), according to 
the manufacturer’s instructions. The threshold cutoff value for 
a specific IgE level was 0.35 kU/L, as measured by UniCAP. The 
presence of rhinosinusitis and nasal polyps was determined us-
ing paranasal sinus X-ray and rhinoscopy. 
Informed consent was obtained from all subjects. The Institu-
tional Review Board of Ajou University Hospital approved the 
study.
SNP identification and genotyping
Forty healthy Korean volunteers were used for SNP identifica-
tion. Genomic DNA was prepared from peripheral blood sam-
ples using the Puregene DNA purification kit (Gentra, Minne-
apolis, MN, USA), according to the manufacturer’s protocol. Our 
objective was to screen promoter, 5’-UTR, and non-synonymous 
coding SNPs. We selected upstream of exon 1 and exon 2 in the 
promoter and 5’-UTR SNP screening. The other SNP located in 
the exon 4 coding region was non-synonymous; it was chosen 
based on functional importance, as reported previously.
12 Direct 
sequencing was performed in the TLR3 region upstream of ex-
ons 1 and 2, and at the exon 4 coding region to examine SNPs 
using the ABI Prism 3100 DNA analyzer (Applied Biosystems, 
Foster City, CA, USA). Two polymorphisms of TLR3 (-299698
G>T) (rs3775296) in the 5’-UTR and 293391G>A [Leu412Phe]) 
(rs3775291) in the coding exon were screened and genotyped 
using a primer extension method and the SNAPshot ddNTP 
primer extension kit (Applied Biosystems). No SNP was found 
upstream of exon 1. The genotyped sample size was based on our 
enrolled sample for the three study groups, AERD, ATA, and NC.
Statistical analyses
The χ2 test was used to detect a significant departure in geno-
type frequency from Hardy–Weinberg equilibrium at each SNP. 
Differences in the mean values of phenotypic characteristics 
among AERD patients were compared using the t test. Differ-
ences in genotype frequency between the two groups were ex-
amined using the χ2 test, and three logical regression models 
(co-dominant, dominant and recessive) were used after account-
ing for age and gender covariates. Pair-wise linkage disequilibri-
um between SNP loci was measured using the absolute value of 
Lewontin’s D’ and r
2. The level of statistical significance was set 
at P<0.05.
RESULTS
Clinical characteristics of the study subjects
The clinical characteristics of the study subjects are presented 
in Table 1. The frequency of atopy was significantly lower in the 
AERD group than ATA (P=0.009) and NC (P<0.001) groups. The 
AERD patients had a significantly higher frequency of rhinosi-
nusitis, compared with the ATA (P=0.04) and NC (P<0.001) Toll-like Receptor 3 Variants in AERD AAIR 
Allergy Asthma Immunol Res. 2011 April;3(2):123-127.  doi: 10.4168/aair.2011.3.2.123 125 http://e-aair.org
groups. The incidence of paranasal sinusitis (P<0.001) and na-
sal polyps (P<0.001) was significantly higher in the AERD than 
the ATA group. Serum total IgE was significantly higher in the 
AERD than the NC group (P<0.001). The PC20 methacholine 
level was significantly lower in the AERD compared with the 
ATA group (P<0.001).
Allele and genotype frequencies of the TLR3 gene with the 
AERD phenotype 
Genetic associations were examined between two genetic 
polymorphisms of TLR3 (299698G>T and -293391G>A) in the 
three study groups. The genotype distribution of the two poly-
morphisms did not depart significantly from Hardy–Weinberg 
equilibrium (P>0.05). 
The AERD patients who carried the GG genotype of -293391 
G>A showed a significantly lower frequency than the ATA group 
in co-dominant (P=0.025) and dominant (P=0.036) models. 
Similarly, the minor allele frequency ‘A’ allele was significantly 
higher in the AERD versus the ATA group (P=0.023) for this 
polymorphism. AERD patients who carried the GT and TT gen-
otype of 299698G>T showed significantly lower frequencies 
than in the ATA group (P=0.048) in the recessive model of anal-
ysis (Table 2). However, no significant difference was obtained 
in the case of genotype frequencies between AERD and NC, 
and ATA and NC of the TLR3 299698G>T or -293391G>A genet-
ic polymorphisms. The statistical power for a significant result 
in AERD versus ATA for Leu412Phe (293391G>A) was 41%.
Haplotype frequency of the TLR3 gene with the AERD 
phenotype
Two polymorphisms in the TLR3 gene were in linkage disequi-
librium (D’=1 and r
2=0.111), and three common haplotypes, 
HT1 [GG], HT2 [GA] and HT3 [TG] were constructed using the 
Haploview program. Significant differences were observed in 
Table 1.  Clinical characteristics of the AERD study subjects
Characteristics AERD (n=203) ATA (n=254) NC (n=274)
P value*
AERD vs. ATA ATA vs. NC AERD vs. NC
Age (yr) 43.9±13 43.1±15.2 32.1±12.7 0.546 <0.001 <0.001
Gender (male, %) 72 (35.5) 112 (44.1) 108/273 (39.6) 0.062 0.292 0.362
Atopy (+, %) 94 (52.8) 115 (66.5) 27/165 (16.4) 0.009 <0.001 <0.001
Asthma duration (yr) 6.3±5.8 5.2±6.1 NA 0.143 NA NA
FEV1 (%) 80.5±23.2 88.7±20.5 98.7±7/9 0.001 0.002 <0.001
PC20, methacholine (mg/mL) 4.1±7.2 7.8±9.4 NA <0.001 NA NA
Serum total IgE (IU/mL) 340.5±441.7 401.4±639.8 105.2±178 0.369 <0.001 <0.001
Rhinosinusitis (+, %) 114 (85.7) 132 (76.3) 3 (33.3) 0.040 0.004 <0.001
Paranasal sinusitis (+, %) 74 (57.4) 12 (7.0) NA <0.001 NA NA
Nasal polyp (+, %) 56 (44.4) 9 (5.3) NA <0.001 NA NA
ECP (µg/mL) 20.9±20 24.5±25.9 NA 0.398 NA NA
*P values were determined using Pearson’s χ2 test for categorical variables and the t test for continuous variables. Values in bold indicate a significant P value.
AERD, aspirin-exacerbated respiratory disease; ATA, aspirin-tolerant asthma; NC, normal control; NA, not applicable; FEV1, forced expiratory volume; ECP, eosinophil 
cationic protein.
Table 2.  Allele and genotype frequencies of TLR3 gene
SNP loci Genotype AERD (n=203) ATA (n=254) NC (n=274)
P value*
AERD vs. ATA AERD vs. NC ATA vs. NC
-299698G>T GG 132 (65.00%) 142 (55.90%) 162 (59.10%) 0.082 0.418 0.438
(rs 3775296) GT 62 (30.50%) 99 (39.00%) 92 (33.60%) 0.806 0.289 0.306
TT 9 (4.40%) 13 (5.10%) 20 (7.30%) 0.048 0.624 0.149
q 0.197 0.246 0.241 0.083 0.403 0.437
293391G>A GG 96 (47.30%) 141 (55.50%) 145 (52.90%) 0.025 0.366 0.812
(rs3775291) GA 83 (40.90%) 97 (38.20%) 116 (42.30%) 0.036 0.118 0.873  
AA 24 (11.80%) 16 (6.30%) 13 (4.70%) 0.087 0.759 0.72
  q 0.323 0.254 0.259 0.023 0.375 0.818
*Each P value was calculated with co-dominant, dominant, and recessive models. Logistic regression analysis was applied to control for age and gender as covari-
ables q; minor allele frequency. Values in bold indicate significant P values.
AERD, aspirin-exacerbated respiratory disease; ATA, aspirin-tolerant asthma; NC, normal control.Palikhe et al.
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the haplotype frequencies among the three groups. The AERD 
patients who carried homozygous HT2 [GA] showed a signifi-
cantly higher frequency than other haplotypes in co-dominant 
(P=0.02) and recessive (P=0.026) models (Table 3).
DISCUSSION
We evaluated the associations of two genetic polymorphisms 
of TLR3 in the three study groups, AERD, ATA, and NC, in a Ko-
rean population. To our knowledge, this is the first reported study 
to investigate the genetic polymorphisms of the 5’-UTR of TLR3, 
-299698G>T, and the coding region, Leu412Phe (293391G>A), 
in AERD patients.
Our genotype, allele, and haplotype results suggest that poly-
morphism in the TLR3 gene is associated with AERD in the Ko-
rean population. However, we did not find any clinical evidence 
that patients with AERD were more prone than those with ATA 
to viral infection or virus-induced asthma exacerbation. A pre-
vious study has shown that there was no association of TLR3 
-299698G>T and Leu412Phe (293391G>A) SNPs with asthma 
and total serum IgE level in a Japanese population.
18 However, 
-299698G>T was found to be strongly associated with SJS in the 
same population,
12 which raises the possibility of a link between 
TLR3 gene polymorphisms and viral infections. The suggested 
mechanism is that specific cytotoxic lymphocytes are produced 
in response to virus infection. The activity of these lymphocytes 
is suppressed by prostaglandin E2 (PGE2), which is produced 
by pulmonary alveolar macrophages. If PGE2 removal occurs, 
cytotoxic reactions are preceded by COX inhibitors and cyto-
toxic-lymphocyte-mediated attack and destruction of virus-af-
fected cells in the respiratory tract. Reactive oxygen species, tox-
ic metabolites, and mediators released then precipitate asthma 
attacks.
1,19 Overproduction of cysteinyl leukotrienes (cys-LTs) is 
unique to mast cells in AERD patients, and is particularly sensi-
tive to suppression by PGE2. Consequently, reduction of PGE2 
production, by aspirin, removes this endogenous control of cys-
LT overproduction, which can result in asthma exacerbation.
20 
These findings suggest that TLR3 polymorphisms may be asso-
ciated with the AERD phenotype in the Korean population.
Significantly higher minor allele frequency in AERD versus 
ATA indicated that the “A” allele of 293391G>A (Leu412Phe) 
might be involved in susceptibility to AERD pathogenesis. The 
change in amino acid from Leu to Phe results in functional de-
terioration of TLR3 and predisposes individuals to increased 
susceptibility to viral infections, which could be a potential 
cause of viral-induced AERD. A functional requirement for TLR3 
in the host response against rhinovirus infection has also been 
proposed. TLR3 is expressed in dendritic cells and airway epi-
thelial cells. TLR3 signaling activates the transcription of NF-κB 
and interferon regulatory factor 1 (IRF-3). IRF-3 induces expres-
sion of type 1 interferons that contribute to antiviral effects via 
activation of other genes. The non-synonymous SNP of TLR3 
has been previously tested for alteration of the function of TLR3, 
and its detrimental effect on TLR3 activity has been confirmed. 
TLR3-dependent activation of a firefly luciferase reporter driv-
en by NF-κB has reduced reporter activity of NF-κB promoter 
by 30%.
12 Additionally, the frequency of the Phe allele of TLR3 
in viral infection and patients with sub-acute sclerosing panen-
cephalitis is significantly higher than in controls in Japan.
21 This 
could be due to destabilization of the solenoid structure by 
412Phe, and might disrupt potential glycosylation of the neigh-
boring residue, Asn413, which has been shown to have N-acetyl-
glucosamine residues attached.
20 The 412Phe allele of TLR3 
gene shows reduced interferon production in response to syn-
thetic dsRNA,
12 as shown by reporter assay-dependent TLR3 
activation. L412F mutations show decreased cell surface abun-
dance of these TLR3 proteins, by flow cytometry analysis, and 
might affect the normal dimerization of TLR3 by improper tar-
geting of the protein. Thus, TLR3 polymorphism might contrib-
ute to the induction of frequent viral infections in relation to 
Table 3.  Haplotype analysis of TLR3 -299698G>T and TLR3 293391G>A in study subjects
    AERD (n=203) ATA (n=253) NC (n=274)
P value*
AERD vs. ATA AERD vs. NC ATA vs. NC
HT1[GG] ht1/ht1 48 (23.60%) 64 (25.30%) 69 (25.20%) 0.477 0.917 0.732
ht1/- 99 (48.80%) 127 (50.20%) 136 (49.60%) 0.469 0.843 0.898
 -/- 56 (27.60%) 62 (24.50%) 69 (25.20%) 0.662 0.977 0.666
HT2[GA] ht2/ht2 24 (11.80%) 15 (5.90%) 13 (4.7%) 0.020 0.366 0.731
ht2/- 83 (40.90%) 97 (38.30%) 116 (42.30%) 0.079 0.759 0.685
 -/- 96 (47.30%) 141 (55.70%) 145 (52.90%) 0.026 0.118 0.989
HT3[TG] ht3/ht3 9 (4.40%) 13 (5.10%) 20 (7.30%) 0.088 0.418 0.459
ht3/- 62 (30.50%) 98 (38.70%) 92 (33.60%) 0.053 0.624 0.163
   -/- 132 (65.00%) 142 (56.10%) 162 (59.10%) 0.798 0.289 0.312
*Each P value was calculated with co-dominant, dominant, and recessive models. Values in bold indicate significant P values.
AERD, aspirin-exacerbated respiratory disease; ATA, aspirin-tolerant asthma; NC, normal control.Toll-like Receptor 3 Variants in AERD AAIR 
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TLR3 instability, or augmentation of inflammatory responses 
within cells.
12,21,23 More specifically, the ‘A’ allele of 293391G>A 
[Leu412Phe] might be involved in susceptibility to TLR3-medi-
ated viral infections, which could contribute to the develop-
ment and exacerbation of asthmatic symptoms in AERD pa-
tients. Despite limitations with regard to sample size and statis-
tical power, this genetic polymorphism may provide useful in-
formation for those investigating the mechanism of AERD as-
sociated with viral infection. Further study is needed in larger 
cohorts to obtain a better understanding of the mechanism of 
AERD associated with viral infection.
In conclusion, our findings suggest that the TLR3 -299698G>T 
and 293391G>A [Leu412Phe] polymorphisms of the TLR3 gene 
are associated with the AERD phenotype. More specifically, the 
‘A’ allele [412Phe] of non-synonymous SNP 293391G>A [Leu-
412Phe] may be associated with TLR3-mediated viral infection 
in AERD patients.
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